CareDx Seeks High Court Review Of $45M False Ad Case
By Ivan Moreno · February 13, 2026, 2:10 PM EST
Transplant diagnostics company CareDx has asked the U.S. Supreme Court to review a Third Circuit decision that erased a nearly $45 million jury award against rival Natera in a false advertising...
To view the full article, register now.